Lynx1 Capital Management LP - Insider Non-Derivative Transactions at Neuphoria Therapeutics Inc. (NEUP) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Oct 21, 2025, Lynx1 Capital Management LP's relationship to Neuphoria Therapeutics Inc. (NEUP) is TenPercentOwner, and currently has 875,328 shares of Common stock, $0.00001 par value per share.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other NEUP insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Lynx1 Capital Management LP - Insider Non-Derivative Transactions of NEUP Common stock, $0.00001 par value per share

Lynx1 Capital Management LP - Insider Non-Derivative Transactions at NEUP

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 22, 2025	P -- (Common stock, $0.00001 par value per share)	639110	5.14	875328